Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial

Authors

Institutions

Publication Details

Journal
Cardio-Oncology
Published
2025-05-17
DOI
https://doi.org/10.1186/s40959-025-00344-3
Citations
2
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
2.78

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial

Johanne Dam Lyhne, Birgitte Mayland Havelund, Susanne Hosbond, Vibeke Hansen et al.
2 citations
Cardio-Oncology
Chemotherapy-induced cardiotoxicity and mitigation
2.78
article

Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial

Johanne Dam Lyhne, Birgitte Mayland Havelund, Susanne Hosbond, Vibeke Hansen, Lars Henrik Jensen, Martin Busk, Mads Dam Lyhne, Signe Timm, Lone Due Vestergaard, Torben Hansen, Else Maae, Mayooran Gnanaganesh
article en
2 citations

Abstract

No abstract available for this paper.
Cardio-OncologyVol. 11(1)
Aarhus University (DK), Aarhus University Hospital (DK), Vejle Sygehus (DK), Region of Southern Denmark (DK)
Syddansk Universitet
Openalex Percentile: Top 10%
Chemotherapy-induced cardiotoxicity and mitigation
2.78
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.